Treatment approaches for managing patients with hematological malignancies in the time of COVID-19 pandemic

References (1)

1. Mutnal MB, Arroliga AC, Walker K, Mohammad A, Brigmon MM et al. Early trends for SARS-CoV-2 infection in central and north Texas and impact on other circulating respiratory viruses. Journal of Medical Virology 2020; 92 (10): 2130-2138. doi: 10.1002/jmv.26010 2- Ljungman P, Mikulska M, De la Camara R, Basak GW, Chabannon C et al. European Society for Blood and Marrow Transplantation: the challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy. Bone Marrow Transplantation 2020; 55 (11): 2071-2076. 3- Al Saleh AS, Sher T, Gertz MA. Multiple myeloma in the time of COVID-19. Acta Haematologica 2020; 143 (5): 410-416. doi: 10.1159/000507690 4- Percival MEM, Lynch RC, Halpern AB, Shadman M, Cassaday RD et al. Consideration for managing patients with hematologic malignancy during the COVID-19 pandemic: the Seattle strategy. JCO Oncology Practice 2020; 16 (9): 571-578. doi: 10.1200/OP.20.00241 5- Gavillet M, Carr Klappert J, Spertini O, Blum S. Acute leukemia in the time of COVID-19. Leukemia Research 2020; 92: 106353. doi: 10.1016/j.leukres.2020.106353 6- Paul S, Rausch CR, Jain N, Kadia T, Ravandi F et al. Treating leukemia in the time of COVID-19. Acta Haematologica 2020; 11: 1-13. doi: 10.1159/000508199 7- Demirer T, Gooley T, Buckner CD, Petersen FB, Lilleby K et al. The influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation. Bone Marrow Transplantation 1995; 15 (6): 907-913. 8- Kröger N, Damon L, Zander A R, Wandt H, Derigs G et al. Secondary acute leukemia following mitoxantrone based highdose chemotherapy for primary breast cancer patients. Bone Marrow Transplantation 2003; 32: 1153-1157. doi: 10.1038/sj.bmt.1704291 9- Zeidan AM, Boddu PC, Patnaik MM, Bewersdorf JP, Stahl M et al. Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID19 era: recommendations from a panel of international experts. Lancet Haematology 2020; 7 (8): 601-612. doi: 10.1016/S2352-3026(20)30205-2 10- Brissot E, Labopin M, Baron F, Bazarbachi A, Bug G et al. Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation. Bone Marrow Transplantation 2020; 11